<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="ribavirin/PMC5923505/results/search/disease/results.xml">
  <result pre="herpesviruses, zidovudine for human immunodeficiency virus (HIV), and sofosbuvir for" exact="hepatitis" post="C virus (HCV)) have been successful in clinical trials"/>
  <result pre="of RNA viruses, including Middle East respiratory syndrome coronavirus (MERS-CoV)," exact="severe acute respiratory syndrome" post="coronavirus (SARS-CoV), Zika virus (ZIKV), HCV, poliovirus (PV), influenza"/>
  <result pre="respiratory syndrome coronavirus (SARS-CoV), Zika virus (ZIKV), HCV, poliovirus (PV)," exact="influenza" post="A virus (IAV), HIV, and enteroviruses (EV) [13,14,15,16,17,18]. The"/>
  <result pre="can infect pregnant women and cause congenital abnormalities such as" exact="microcephaly" post="in infants, which has attracted increasing public attention as"/>
  <result pre="respectively [17,19], which were lower concentrations than those used in" exact="cancer" post="therapy [20]. In the case of HIV, the combination"/>
  <result pre="gemcitabine with decitabine, another nucleoside analog in clinical use for" exact="cancer" post="therapy, synergistically reduced HIV infectivity by increasing the viral"/>
  <result pre="reported the antiviral effect of gemcitabine against HIV-related retrovirus, murine" exact="leukemia" post="virus (MuLV), in vitro (EC50 of 1.6 nM) and"/>
  <result pre="and found its strong inhibitory effect on Sindbis virus and" exact="herpes simplex" post="virus-1 (HSV-1) (&amp;gt;2 log reduction in virus titer) but"/>
  <result pre="and human echovirus 6, and minimal effects on Bunyamwera virus," exact="measles" post="virus (MeV), and vaccinia virus [16]. The antiviral effect"/>
  <result pre="and minimal effects on Bunyamwera virus, measles virus (MeV), and" exact="vaccinia virus" post="[16]. The antiviral effect of gemcitabine on EVs, initially"/>
  <result pre="low nanomolar EC50, which was lower than that used in" exact="cancer" post="therapy [14,20]. Even for other viruses with a relatively"/>
  <result pre="decades. Both have antiviral activities against viruses such as HCV," exact="hepatitis" post="E virus (HEV), MERS-CoV, dengue virus, yellow fever, hepatitis"/>
  <result pre="such as HCV, hepatitis E virus (HEV), MERS-CoV, dengue virus," exact="yellow fever," post="hepatitis B virus, West Nile virus (WNV), Chikungunya virus"/>
  <result pre="HCV, hepatitis E virus (HEV), MERS-CoV, dengue virus, yellow fever," exact="hepatitis" post="B virus, West Nile virus (WNV), Chikungunya virus (CHIKV),"/>
  <result pre="1.JordheimL.P.DurantelD.ZoulimF.DumontetC.Advances in the development of nucleoside and nucleotide analogues for" exact="cancer" post="and viral diseasesNat. Rev. Drug Discov.20131244746410.1038/nrd401023722347 2.ElionG.B.The purine path"/>
  <result pre="2.ElionG.B.The purine path to chemotherapyScience1989244414710.1126/science.26499792649979 3.WhitleyR.J.AlfordC.A.HirschM.S.SchooleyR.T.LubyJ.P.AokiF.Y.HanleyD.NahmiasA.J.SoongS.J.Vidarabine versus acyclovir therapy in" exact="herpes simplex" post="encephalitisN. Eng. J. Med.198631414414910.1056/NEJM1986011631403033001520 4.KahnJ.O.LagakosS.W.RichmanD.D.CrossA.PettinelliC.LiouS.H.BrownM.VolberdingP.A.CrumpackerC.S.BeallG.et al.A controlled trial comparing"/>
  <result pre="zidovudine with didanosine in human immunodeficiency virus infection. The niaid" exact="aids" post="clinical trials groupN. Eng. J. Med.199232758158710.1056/NEJM1992082732709011353607 5.LawitzE.MangiaA.WylesD.Rodriguez-TorresM.HassaneinT.GordonS.C.SchultzM.DavisM.N.KayaliZ.ReddyK.R.et al.Sofosbuvir for"/>
  <result pre="groupN. Eng. J. Med.199232758158710.1056/NEJM1992082732709011353607 5.LawitzE.MangiaA.WylesD.Rodriguez-TorresM.HassaneinT.GordonS.C.SchultzM.DavisM.N.KayaliZ.ReddyK.R.et al.Sofosbuvir for previously untreated chronic" exact="hepatitis" post="C infectionN. Eng. J. Med.20133681878188710.1056/NEJMoa121485323607594 6.ThomasE.FeldJ.J.LiQ.HuZ.FriedM.W.LiangT.J.Ribavirin potentiates interferon action"/>
  <result pre="6.ThomasE.FeldJ.J.LiQ.HuZ.FriedM.W.LiangT.J.Ribavirin potentiates interferon action by augmenting interferon-stimulated gene induction in" exact="hepatitis" post="c virus cell culture modelsHepatology201153324110.1002/hep.2398521254160 7.LeyssenP.BalzariniJ.de ClercqE.NeytsJ.The predominant mechanism"/>
  <result pre="by inhibition of imp dehydrogenaseJ. Virol.2005791943194710.1128/JVI.79.3.1943-1947.200515650220 8.DebingY.EmersonS.U.WangY.PanQ.BalzariniJ.DallmeierK.NeytsJ.Ribavirin inhibits in vitro" exact="hepatitis" post="e virus replication through depletion of cellular gtp pools"/>
  <result pre="talk between nucleotide synthesis pathways with cellular immunity in constraining" exact="hepatitis" post="e virus replicationAntimicrob. Agents Chemother.2016602834284810.1128/AAC.02700-1526926637 11.HertelL.W.BoderG.B.KroinJ.S.RinzelS.M.PooreG.A.ToddG.C.GrindeyG.B.Evaluation of the antitumor"/>
  <result pre="antipoliovirus agentACS Infect. Dis.20173455310.1021/acsinfecdis.6b0011627733043 16.DenisovaO.V.KakkolaL.FengL.StenmanJ.NagarajA.LampeJ.YadavB.AittokallioT.KaukinenP.AholaT.et al.Obatoclax, saliphenylhalamide, and gemcitabine inhibit" exact="influenza" post="a virus infectionJ. Biol. Chem.2012287353243533210.1074/jbc.M112.39214222910914 17.ClouserC.L.HoltzC.M.MullettM.CrankshawD.L.BriggsJ.E.O’SullivanM.G.PattersonS.E.ManskyL.M.Activity of a novel"/>
  <result pre="inhibitor from an hsp90 inhibitor as a selective inhibitor of" exact="hepatitis" post="C virusPLoS ONE20127e3028610.1371/journal.pone.003028622347373 20.GrunewaldR.KantarjianH.DuM.FaucherK.TarassoffP.PlunkettW.Gemcitabine in leukemia: A phase I"/>
  <result pre="and broad-spectrum in vitro antiviral activity against pandemic, seasonal and" exact="avian influenza" post="viruses affecting humansJ. Gen. Virol.2016971807181710.1099/jgv.0.00051227259985 25.MorreyJ.D.SmeeD.F.SidwellR.W.TsengC.Identification of active antiviral"/>
  <result pre="broad-spectrum in vitro antiviral activity against pandemic, seasonal and avian" exact="influenza" post="viruses affecting humansJ. Gen. Virol.2016971807181710.1099/jgv.0.00051227259985 25.MorreyJ.D.SmeeD.F.SidwellR.W.TsengC.Identification of active antiviral"/>
  <result pre="enzyme activity is a potential target for the inhibition of" exact="chikungunya" post="virus replication and virus induced apoptosis in cultured mammalian"/>
  <result pre="der LaanL.J.NeytsJ.JanssenH.L.MetselaarH.J.PeppelenboschM.P.PanQ.Calcineurin inhibitors stimulate and mycophenolic acid inhibits replication of" exact="hepatitis" post="E virusGastroenterology20141461775178310.1053/j.gastro.2014.02.03624582714 30.PanQ.de RuiterP.E.MetselaarH.J.KwekkeboomJ.de JongeJ.TilanusH.W.JanssenH.L.van der LaanL.J.Mycophenolic acid augments"/>
  <result pre="JongeJ.TilanusH.W.JanssenH.L.van der LaanL.J.Mycophenolic acid augments interferon-stimulated gene expression and inhibits" exact="hepatitis" post="C virus infection in vitro and in vivoHepatology2012551673168310.1002/hep.2556222213147 31.PanattoniA.D’AnnaF.TrioloE.Antiviral"/>
  <result pre="Sci. USA20111086739674410.1073/pnas.101714210821502533 41.WangQ.Y.BushellS.QingM.XuH.Y.BonaviaA.NunesS.ZhouJ.PohM.K.Florez de SessionsP.NiyomrattanakitP.et al.Inhibition of dengue virus through" exact="suppression" post="of host pyrimidine biosynthesisJ. Virol.2011856548655610.1128/JVI.02510-1021507975 42.SmeeD.F.HurstB.L.DayC.W.D282, a non-nucleoside inhibitor"/>
  <result pre="of host pyrimidine biosynthesisJ. Virol.2011856548655610.1128/JVI.02510-1021507975 42.SmeeD.F.HurstB.L.DayC.W.D282, a non-nucleoside inhibitor of" exact="influenza" post="virus infection that interferes with de novo pyrimidine biosynthesisAntivir."/>
 </snippets>
</snippetsTree>
